Paul Spencer is head of the Drug Delivery & Products unit at Evonik Health Care. This unit focuses on advancing the company’s system solutions for complex oral and parenteral drug delivery including the strong portfolio of excipients – EUDRAGIT® and RESOMER® – lipids and lipid nanoparticles (LNPs), with complementary CDMO services from feasibility studies to commercial drug products. Paul has more than 30 years’ experience in the pharmaceutical industry with extensive knowledge of drug delivery and biomaterials.